Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This is a pragmatic randomized open-label study of the safety and efficacy of the combination
of colchicine and Rosuvastatin in addition to standard of care (SOC) compared to SOC alone in
hospitalized patients with SARS-CoV-2